Newswise — Should health professionals use experimental treatments on humans? Most would say “no” but when it comes to Ebola, the answer gets a bit more complicated. University of Louisville professor Mark Rothstein can address the ethical implications of using the drug ZMapp and who should get it. He can also discuss other ethical issues such as quarantine and isolation, travel restrictions and allocation of resources. Rothstein is director of the Bioethics Institute at the U of L School of Medicine and can be reached at 502-852-4982 or at email@example.com.